Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
InChi: InChI=1S/C33H35FO4/c1-33(2)15-5-8-30(33)28-16-21(9-13-26(28)29-18-24(37-3)12-14-31(29)34)20-38-25-7-4-6-23(17-25)27(19-32(35)36)22-10-11-22/h4
Clinical trial: The safety and efficacy of a combination of dihydroartemisinin (DHA) and piperaquine was assessed in patients with uncomplicated falciparum malaria
Chemical Name: 3-{[2-(4-fluorophenyl)ethyl]amino}-1-methyl-4-(2-methyl-1H-indol-3-yl)-2
4]triazin-7-yl}oxy)methyl methyl carbonate
H358 and H460 cells
OVA Peptide(257-264) TFA rothionamide InChi: InChI=1S/C33H35FO4/c1-33(2)15-5-8-30(33)28-16-21(9-13-26(28)29-18-24(37-3)12-14-31(29)34)20-38-25-7-4-6-23(17-25)27(19-32(35)36)22-10-11-22/h4OVA Peptide(257 264) TFA is a class I (Kb) restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H 2Kb. Product information CAS Number: 1262751 08 5 Molecular Weight: 1077. 15 Formula: C47H75F3N10O15 Chemical Name: (2S) 2 [(2S) 6 amino 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S,3S) 2 [(2S,3S) 2 [(2S) 2 amino 3 hydroxypropanamido] 3 methylpentanamido] 3 methylpentanamido] 3 carbamoylpropanamido] 3
US$ 205.55
US$ 135.50
US$ 173.00
US$ 55.16
US$ 89.98